B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Dabigatran

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dabigatran, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

melagatran
5 shared targets
efegatran
4 shared targets
camostat
5 shared targets
argatroban
3 shared targets
dx
3 shared targets
epinastine
3 shared targets
Gabexate
5 shared targets · score 50.2
pantoprazole
3 shared targets
nafamostat
4 shared targets
edoxaban
2 shared targets
Loading evidence profile...

This evidence profile for Dabigatran is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.